13 Results for "

MES seizure

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "MES seizure" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-B1730
CAS No.: 86-34-0
Phensuximide is an orally active succinimide antiepileptic and anticonvulsant agent. Phensuximide inhibits cyclic AMP and cyclic GMP accumulation in depolarized brain tissue. Phensuximide can be used for the study of seizure and petit mal .
loading...
    loading...
Cat. No.: HY-172431
CAS No.: 2376397-93-0
Synonyms: BHV-7000
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

Opakalim (BHV-7000) is a selective Kv7.2/7.3 potassium channels activator with an EC50 of 0.6 μM. Opakalim shows minimal GABAA receptor activation and exhibits potent anti-seizure efficacy in the maximal electroshock seizure (MES) model. Opakalim can be used for the study of seizures .
loading...
    loading...
Cat. No.: HY-168773
CAS No.: 2506367-95-7
Target:  

EAAT

Research Areas:  

Neurological Disease

(R)-AS-1 is a selective positive allosteric modulator of the excitatory amino acid transporter 2 (EAAT2), with an EC50 of 11 nM. (R)-AS-1 (at doses of 60 and 90 mg/kg) increases spontaneous locomotor activity in mice. Additionally, it demonstrates anticonvulsant activity in mouse models of seizures induced by maximal electroshock (MES), pentylenetetrazole (PTZ), or electrical stimuli (32 or 44 mA), with ED50s of 66.3, 36.3, 15.6, and 41.6 mg/kg, respectively. (R)-AS-1 can be used in neurological disease research .
loading...
    loading...
Cat. No.: HY-W012481
CAS No.: 631-07-2
Synonyms: Ethylphenylhydantoin; Phenylethyihydantoin; Desmethylmephenytoin
Target:  

Drug Metabolite

Research Areas:  

Neurological Disease

Nirvanol (Ethylphenylhydantoin) is a metabolite of Mephenytoin (HY-B1184) that exerts anticonvulsant effects in the maximal electroshock (M.E.S.) seizure model in mice. Nirvanol shows potential for research in epilepsy-related neurological disorders .
loading...
    loading...
Cat. No.: HY-175340
CAS No.: 1361107-81-4
Target:  

Potassium Channel TSPO

Research Areas:  

Neurological Disease

Kv7.2/Kv7.3 activator-3 (GRT-X) is an orally active Kv7.2/Kv7.3 and TSPO activator. Kv7.2/Kv7.3 activator-3 activates Kv7.2/Kv7.3, Kv7.4, and Kv7.5 with EC50 values of 0.37, 2.06, and 0.75 μM, respectively, and binds to TSPO with Ki values of 0.07 μM (rat membrane) and 4.60 μM (human U-118 MG cells). Kv7.2/Kv7.3 activator-3 prevents motor neuron degeneration in mice and humans conditioned by ALS/FTD astrocytes. Kv7.2/Kv7.3 activator-3 stimulates dorsal root ganglion axonal growth through TSPO and Kv7.2/3 activation. Kv7.2/Kv7.3 activator-3 has anti-epileptic effects in epileptic seizure models. Kv7.2/Kv7.3 activator-3 reduces pain hypersensitivity in patients with diabetic neuropathy, promotes neuronal survival and regeneration after cervical neuropathy in rats, and accelerates the recovery of normal function of sensory and motor neurons .
loading...
    loading...
Cat. No.: HY-119461
CAS No.: 5579-13-5
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

Capuride is an orally active sedative agent. Capuride has anticonvulsant activity .
loading...
    loading...
Cat. No.: HY-106424
CAS No.: 130403-08-6
Target:  

Drug Intermediate

Research Areas:  

Neurological Disease

Soretolide is an antiepileptic agent. Soretolide is effective in maximal electroshock-induced seizure (MES) test in rodents. Soretolide inhibits metabolism of Phenytoin (HY-B0448). Soretolide exhibits a good pharmacokinetic character in rats model .
loading...
    loading...
Cat. No.: HY-W012481R
CAS No.: 631-07-2
Synonyms: Ethylphenylhydantoin (Standard); Phenylethyihydantoin (Standard); Desmethylmephenytoin (Standard)
Research Areas:  

Neurological Disease

Nirvanol (Ethylphenylhydantoin) is a metabolite of Mephenytoin (HY-B1184) that exerts anticonvulsant effects in the maximal electroshock (M.E.S.) seizure model in mice. Nirvanol shows potential for research in epilepsy-related neurological disorders .
loading...
    loading...
Cat. No.: HY-B1730R
CAS No.: 86-34-0
Phensuximide (Standard) is the analytical standard of Phensuximide. This product is intended for research and analytical applications. Phensuximide is an orally active succinimide antiepileptic and anticonvulsant agent. Phensuximide inhibits cyclic AMP and cyclic GMP accumulation in depolarized brain tissue. Phensuximide can be used for the study of seizure and petit mal .
loading...
    loading...
Cat. No.: HY-W012481S
CAS No.: 119458-27-4
Synonyms: Ethylphenylhydantoin-d5; Phenylethyihydantoin-d5; Desmethylmephenytoin-d5
Nirvanol-d5 (Ethylphenylhydantoin-d5) is deuterium labeled Nirvanol (HY-W012481) . Nirvanol (Ethylphenylhydantoin) is a metabolite of Mephenytoin (HY-B1184) that exerts anticonvulsant effects in the maximal electroshock (M.E.S.) seizure model in mice. Nirvanol shows potential for research in epilepsy-related neurological disorders .
loading...
    loading...
Cat. No.: HY-178016
CAS No.: 3097193-89-7
Target:  

Histamine Receptor

Research Areas:  

Neurological Disease

H3R antagonist 8 is a selective nonimidazole histamine H3 receptor antagonist (IC50 = 0.35 μM). H3R antagonist 8 exhibits hERG channel blockade activity (IC50 = 0.67 μM). H3R antagonist 8 inhibits seizures by antagonizing H3 receptor. H3R antagonist 8 reduces tonic hind limb extension (THLE) in mice in the maximal electroshock seizure (MES) model (ED50 = 20.21 mg/kg) and and shortens pentylenetetrazol (PTZ)-induced total movement distance in AB strain zebrafish larvae. H3R antagonist 8 can be used for the study of epilepsy .
loading...
    loading...
Cat. No.: HY-108327
CAS No.: 1354712-92-7
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

PF-05020182 is an orally active opener for Kv7 channel, that activates human Kv7.2/7.3, Kv7.4 and Kv7.3/7.5 with EC50 of 334, 625 and 588 nM, respectively. PF-05020182 exhibits anticonvulsant activity in rats corneal electric shock-induced tonic seizure (MES) models. PF-05020182 is blood-brain barrier (BBB) penetrable .
loading...
    loading...
Cat. No.: HY-172887
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

Kv7.2/Kv7.3 activator-2 is a BBB-penetrable Kv7.2/7.3 activator (EC50: 0.25 μM). Kv7.2/Kv7.3 activator-2 has good photostability. Kv7.2/Kv7.3 activator-2 has potently antiepileptic effects in maximal electroshock (MES) and sc-pentylenetetrazol (sc-PTZ)-induced acute mice seizure models .
loading...
    loading...
  • 1